11. International Symposium of Gastroenterology
Data
de 12.5.2016 la 14.5.2016Locul
Rusia, Sankt Petersburg
Țărilor
AUT, BIH, CAN, CZE, DNK, EST, DEU, ITA, KAZ, MNG, POL, SVK, SRB, RUS, ESP, UKR, GBR
Numărul participanților
374
Subiecte
NAFLD and metabolic syndrome; Progress in therapeutic endoscopy; Inflammatory Bowel Disease; Diagnostic and therapeutic approaches in GERD; Hepatology; Colorectal malignancy
Acreditare
“11th International Symposium of Gastroenterology (ISG)” is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS).
“11th International Symposium of Gastroenterology (ISG)” is designated for a maximum of (or ‘for up to’) 9 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Program
Abstracts
Opening session
Metabolic syndrome – Obesity as a risk factor for GI-disease development
Session I: NAFLD and comorbidity
Current approaches to diagnosis and treatment of NAFLD
NAFLD and alcoholic liver disease: Similarities and differences
Session II: Progress in therapeutic endoscopy
Endoscopic surgery – Emerging techniques which completely changed the current clinical practice
The European perspective of endoscopic submucosal dissection
Endoscopic diagnosis and tissue sampling in Barrett’s oesophagus
Is POEM a valid method for the treatment of achalasia patients?
Session III: Inflammatory bowel disease
Progress in conservative therapy in IBD
Can we use the aminosalicylates in clinical practice in IBD patients?
Laparoscopic procedures in IBD: Limits and advantages
Endoscopic surveillance of colorectal carcinoma and dysplasia in IBD patients
Functional GI disorders and IBD debut (clinical cases)
Session IV: Diagnostic and therapeutic approaches in GERD
Questions of diagnostics and treatment of different forms of GERD
GERD complications: Barrett’s metaplasia and others. Recommendation for clinical practice
GERD in patients with metabolic syndrome
Session V: Hepatology
Diagnostic and therapeutic possibilities in primary sclerosing cholangitis
Alcoholic liver diseases: Diagnostic and therapeutic possibilities
Session VI: Colorectal malignancy
Screening of colorectal carcinoma: Hot topics in current clinical gastroenterology
IBD as a risk factor for colorectal carcinoma. A real threat or more likely fiction at this time?
How to make the screening for colorectal carcinoma more effective
Galerie foto ISG 2016
